Pharmaceuticals

Novartis plans to cut 22,00 jobs worldwide

13 Dec 2007

Drug prices fixed under DPCO 1995 have to be compulsorily implemented: Government

11 Dec 2007

Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent

11 Dec 2007

Sun Pharma announces settlement of litigation over generic Exelon

06 Dec 2007

Matrix Labs gets US FDA nod for HIV drug

05 Dec 2007

Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks

05 Dec 2007

French drug giant Sanofi-Aventis opens R&D centre in Goa

05 Dec 2007

Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products

24 Nov 2007

Nicholas Piramal in R&D collaboration with Merck & Co

19 Nov 2007

Pfizer to acquire Coley Pharmaceutical for $164 million

19 Nov 2007

US FDA approval Orchid's ANDA for Cefpodoxime Proxetil

17 Nov 2007

Dr Reddy's gets US FDA nod for marketing Ciprofloxacin

By Our Corporate Bureau | 17 Nov 2007

Glenmark Pharma to spin off generics unit, list new unit next year

17 Nov 2007

Merck agrees to settle Vioxx claims for $4.85 billion

15 Nov 2007

GSK to launch cancer drug Tykerb in India

By Our Corporate Bureau | 10 Nov 2007

Pfizer to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032

By | 01 Nov 2007

Biocon plans Rs 100 crore annual research spend

By Our Corporate Bureau | 31 Oct 2007

Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany

By | 30 Oct 2007

US state Utah seeks co-operation with India in life science research

By | 30 Oct 2007

Glenmark signs up marketing deal with MyerZall Labs

By | 27 Oct 2007

Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa

By | 25 Oct 2007

Ranbaxy launches Osonase nasal spray in India

By | 25 Oct 2007

Suven Life Sciences, University of Minnesota to develop drugs jointly to treat HIV

By | 25 Oct 2007

Dabur enters supply and distribution agreement with Combino Pharm

By Our Corporate Bureau | 24 Oct 2007

US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets

By | 24 Oct 2007